Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation.
Tolosa-Ridao C, Cascos E, Rodríguez-Lobato LG, Pedraza A, Suárez-Lledó M, Charry P, Solano MT, Martinez-Sanchez J, Cid J, Lozano M, Rosiñol L, Esteve J, Urbano-Ispizua Á, Fernández-Avilés F, Martínez C, Carreras E, Díaz-Ricart M, Rovira M, Salas MQ. Tolosa-Ridao C, et al. Among authors: pedraza a. Bone Marrow Transplant. 2024 Mar 23. doi: 10.1038/s41409-024-02270-x. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38521885
A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe.
Gutiérrez-García G, Rovira M, Arab N, Gallego C, Sánchez J, Ángeles Álvarez M, Ayora P, Domenech A, Borràs N, Gerardo Rodríguez-Lobato L, Rosiñol L, Marín P, Pedraza A, Martínez-Roca A, Carcelero E, Dolores Herrera M, Teresa Solano M, Ramos C, de Llobet N, Serrahima A, Lozano M, Cid J, Martínez C, Suárez-Lledó M, Urbano-Ispizua Á, Fernández-Avilés F. Gutiérrez-García G, et al. Among authors: pedraza a. Bone Marrow Transplant. 2020 May;55(5):965-973. doi: 10.1038/s41409-019-0768-x. Epub 2020 Jan 13. Bone Marrow Transplant. 2020. PMID: 31932656
Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis.
Gutiérrez-García G, Villarreal J, Garrote M, Rovira M, Blasco M, Suárez-Lledó M, Rodríguez-Lobato LG, Charry P, Rosiñol L, Marín P, Pedraza A, Solano MT, Ramos C, de Llobet N, Lozano M, Cid J, Martínez C, Poch E, Carreras E, Urbano-Ispizua Á, Fernández-Avilés F, Pereira A, Quintana LF. Gutiérrez-García G, et al. Among authors: pedraza a. Bone Marrow Transplant. 2020 Jul;55(7):1264-1271. doi: 10.1038/s41409-020-0843-3. Epub 2020 Feb 26. Bone Marrow Transplant. 2020. PMID: 32103146
Bacterial Bloodstream Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide.
Salas MQ, Charry P, Puerta-Alcalde P, Martínez-Cibrian N, Solano MT, Serrahima A, Nomdedeu M, Cid J, Lozano M, Chumbinta M, Aiello TF, Arcarons J, LLobet N, Pedraza A, Rosiñol L, Esteve J, Urbano-Ispizua Á, Carreras E, Martínez C, Fernández-Avilés F, García-Vidal C, Suárez-Lledó M, Rovira M. Salas MQ, et al. Among authors: pedraza a. Transplant Cell Ther. 2022 Dec;28(12):850.e1-850.e10. doi: 10.1016/j.jtct.2022.09.001. Epub 2022 Sep 9. Transplant Cell Ther. 2022. PMID: 36089250 Free article.
Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era.
Salas MQ, Rodríguez-Lobato LG, Charry P, Suárez-Lledó M, Pedraza A, Solano MT, Arcarons J, Cid J, Lozano M, Rosiñol L, Esteve J, Carreras E, Fernández-Avilés F, Martínez C, Rovira M. Salas MQ, et al. Among authors: pedraza a. Hematol Transfus Cell Ther. 2023 Oct 12:S2531-1379(23)00162-1. doi: 10.1016/j.htct.2023.07.008. Online ahead of print. Hematol Transfus Cell Ther. 2023. PMID: 37891074 Free article.
Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis.
Escribano-Serrat S, Rodríguez-Lobato LG, Charry P, Martínez-Cibrian N, Suárez-Lledó M, Rivero A, Moreno-Castaño AB, Solano MT, Arcarons J, Nomdedeu M, Cid J, Lozano M, Pedraza A, Rosiñol L, Esteve J, Urbano-Ispizua Á, Palomo M, Fernández-Avilés F, Martínez C, Díaz-Ricart M, Carreras E, Rovira M, Salas MQ. Escribano-Serrat S, et al. Among authors: pedraza a. Cytotherapy. 2024 Jan;26(1):73-80. doi: 10.1016/j.jcyt.2023.10.008. Epub 2023 Nov 10. Cytotherapy. 2024. PMID: 37952139
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation.
Pedraza A, Salas MQ, Rodríguez-Lobato LG, Escribano-Serrat S, Suárez-Lledo M, Martínez-Cebrian N, Solano MT, Arcarons J, Rosiñol L, Gutiérrez-García G, Fernández-Avilés F, Moreno-Castaño AB, Molina P, Pino M, Carreras E, Díaz-Ricart M, Rovira M, Palomo M, Martínez C. Pedraza A, et al. Transplant Cell Ther. 2024 Feb;30(2):187.e1-187.e12. doi: 10.1016/j.jtct.2023.11.016. Epub 2023 Nov 23. Transplant Cell Ther. 2024. PMID: 38000709
Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations.
Salas MQ, Pedraza A, Charry P, Suárez-Lledó M, Rodríguez-Lobato LG, Brusosa M, Solano MT, Serrahima A, Nomdedeu M, Cid J, Lozano M, Arcarons J, de Llobet N, Rosiñol L, Esteve J, Urbano-Ispizua Á, Carreras E, Fernández-Avilés F, Rovira M, Martinez C. Salas MQ, et al. Among authors: pedraza a. Transplant Cell Ther. 2024 Feb;30(2):213.e1-213.e12. doi: 10.1016/j.jtct.2023.11.020. Epub 2023 Nov 30. Transplant Cell Ther. 2024. PMID: 38042256
Improving the EASIX' predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantation.
Escribano-Serrat S, Rodríguez-Lobato LG, Suárez-Lledó M, Pedraza A, Charry P, Cid J, Lozano M, Esteve J, Rosiñol L, Fernández-Avilés F, Carreras E, Díaz-Ricart M, Martínez C, Rovira M, Salas MQ. Escribano-Serrat S, et al. Among authors: pedraza a. Bone Marrow Transplant. 2024 Mar 23. doi: 10.1038/s41409-024-02267-6. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38521886 No abstract available.
High-Dose Cyclophosphamide and Tacrolimus as Graft-versus-Host Disease Prophylaxis for Matched and Mismatched Unrelated Donor Transplantation.
Pedraza A, Jorge S, Suárez-Lledó M, Pereira A, Gutiérrez-García G, Fernández-Avilés F, Rosiñol L, Llobet N, Solano T, Urbano-Ispízua Á, Rovira M, Martínez C. Pedraza A, et al. Transplant Cell Ther. 2021 Jul;27(7):619.e1-619.e8. doi: 10.1016/j.jtct.2021.03.022. Epub 2021 Mar 25. Transplant Cell Ther. 2021. PMID: 33895157 Free article.
126 results